Forma Therapeutics Holdings, Inc. Common Stock
FMTX
FMTX was delisted on the 13th of October, 2022.
93 hedge funds and large institutions have $587M invested in Forma Therapeutics Holdings, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 37 increasing their positions, 20 reducing their positions, and 15 closing their positions.
85% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 20
27% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 15
4% more funds holding
Funds holding: 89 → 93 (+4)
9% less call options, than puts
Call options by funds: $143K | Put options by funds: $158K
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
36% less capital invested
Capital invested by funds: $914M → $587M (-$327M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$32.1M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$10.3M |
| 3 |
State Street
Boston,
Massachusetts
|
+$5.96M |
| 4 |
Renaissance Technologies
New York
|
+$4.43M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$20.7M |
| 2 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
-$18.6M |
| 3 |
LGM
Logos Global Management
San Francisco,
California
|
-$8.91M |
| 4 |
BlackRock
New York
|
-$6.63M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$4.24M |
FMTX Hedge Fund Activity: Q4 2021 in Review
93 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Forma Therapeutics Holdings, Inc. Common Stock (FMTX) for Q4 2021, worth a combined $587M — down 36% from $914M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new FMTX positions and 15 closed out — a net gain of 4 holders — while 37 added to existing stakes and 20 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $32.1M. The largest seller was Fidelity Investments, cutting an estimated $20.7M.
- 93 institutional investors held Forma Therapeutics Holdings, Inc. Common Stock (FMTX) as of Q4 2021, up from 89 in Q3 2021.
- Funds reported $587M of Forma Therapeutics Holdings, Inc. Common Stock stock for Q4 2021, down 36% quarter-over-quarter.
- 19 funds opened new Forma Therapeutics Holdings, Inc. Common Stock positions in Q4 2021 and 15 closed out, a net change of +4 holders.
- The largest Forma Therapeutics Holdings, Inc. Common Stock buyer in Q4 2021 was Armistice Capital, an estimated $32.1M added.
- The largest Forma Therapeutics Holdings, Inc. Common Stock seller in Q4 2021 was Fidelity Investments, an estimated $20.7M sold.
Based on aggregated 13F filings for Q4 2021.